Guardian Pharmacy Services, Inc. Financials
Guardian Pharmacy Services, Inc. (GRDN) reported $1.4B in revenue for fiscal year 2025, up 17.9% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 2 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
A cost-structure reset, not richer unit economics, drove Guardian’s swing to profit and left a more cash-building, debt-free balance sheet.
Between FY2024 and FY2025, gross margin barely moved, so the swing from operating loss to profit was not a story of richer unit economics. Instead, SG&A intensity collapsed from25.0% to15.2% , while cash conversion strengthened enough for operating cash flow to run ahead of net income, implying the turnaround was operationally real rather than just an accounting rebound.
The balance-sheet posture is sturdier because the company finished FY2025 with no long-term debt, cash of
This is a cash-generative, low-capex model rather than one that must constantly reinvest to stand still: free cash flow reached
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Guardian Pharmacy Services, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Guardian Pharmacy Services, Inc. has an operating margin of 5.0%, meaning the company retains $5 of operating profit per $100 of revenue. This results in a moderate score of 30/100, indicating healthy but not exceptional operating efficiency. This is up from -5.1% the prior year.
Guardian Pharmacy Services, Inc.'s revenue surged 17.9% year-over-year to $1.4B, reflecting rapid business expansion. This strong growth earns a score of 79/100.
Guardian Pharmacy Services, Inc. carries a low D/E ratio of 0.00, meaning only $0.00 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 95/100, indicating a strong balance sheet with room for future borrowing.
Guardian Pharmacy Services, Inc.'s current ratio of 1.38 indicates adequate short-term liquidity, earning a score of 36/100. The company can meet its near-term obligations, though with limited headroom.
Guardian Pharmacy Services, Inc. has a free cash flow margin of 6.0%, earning a moderate score of 48/100. The company generates positive cash flow after capital investments, but with room for improvement.
Guardian Pharmacy Services, Inc.'s ROE of 22.6% shows moderate profitability relative to equity, earning a score of 36/100. This is up from -73.4% the prior year.
Guardian Pharmacy Services, Inc. scores 11.90, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($2.4B) relative to total liabilities ($194.7M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Guardian Pharmacy Services, Inc. passes 6 of 8 computable financial strength tests (1 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 2 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
For every $1 of reported earnings, Guardian Pharmacy Services, Inc. generates $2.04 in operating cash flow ($100.3M OCF vs $49.2M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Guardian Pharmacy Services, Inc. earns $109.32 in operating income for every $1 of interest expense ($72.7M vs $665K). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.
Key Financial Metrics
Earnings & Revenue
Guardian Pharmacy Services, Inc. generated $1.4B in revenue in fiscal year 2025. This represents an increase of 17.9% from the prior year.
Guardian Pharmacy Services, Inc.'s EBITDA was $95.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 320.3% from the prior year.
Guardian Pharmacy Services, Inc. reported $49.2M in net income in fiscal year 2025. This represents an increase of 144.7% from the prior year.
Not reported for fiscal year 2025.
Cash & Balance Sheet
Guardian Pharmacy Services, Inc. generated $86.8M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 100.8% from the prior year.
Guardian Pharmacy Services, Inc. held $65.6M in cash against $0 in long-term debt as of fiscal year 2025, with $160.7M of liabilities due within a year.
Not reported for fiscal year 2025.
Margins & Returns
Guardian Pharmacy Services, Inc.'s gross margin was 20.2% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 0.3 percentage points from the prior year.
Guardian Pharmacy Services, Inc.'s operating margin was 5.0% in fiscal year 2025, reflecting core business profitability. This is up 10.1 percentage points from the prior year.
Guardian Pharmacy Services, Inc.'s net profit margin was 3.4% in fiscal year 2025, showing the share of revenue converted to profit. This is up 12.4 percentage points from the prior year.
Guardian Pharmacy Services, Inc.'s ROE was 22.6% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 96.0 percentage points from the prior year.
Capital Allocation
Guardian Pharmacy Services, Inc. invested $13.4M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 8.8% from the prior year.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
GRDN Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 |
|---|---|---|---|
| Revenue | $1.5B | $1.4B+17.9% | $1.2B |
| Cost of Revenue | $1.1B | $1.2B+17.5% | $984.0M |
| Gross Profit | $316.6M | $292.7M+19.8% | $244.4M |
| SG&A Expenses | $231.1M | $220.0M-28.4% | $307.3M |
| Operating Income | $85.4M | $72.7M+215.5% | -$62.9M |
| Interest Expense | $631K | $665K-79.7% | $3.3M |
| Income Tax | $29.3M | $24.5M+437.0% | $4.6M |
| Net Income | $65.9M | $49.2M+144.7% | -$110.0M |
Not reported in any period shown, so not listed: R&D Expenses, EPS (Diluted).
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
GRDN Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY25 | FY24 |
|---|---|---|
| Total Assets | $412.7M+28.6% | $320.8M |
| Current Assets | $221.6M+45.8% | $152.0M |
| Cash & Equivalents | $65.6M+1308.1% | $4.7M |
| Inventory | $43.4M+6.9% | $40.5M |
| Accounts Receivable | $101.6M+4.6% | $97.2M |
| Goodwill | $79.7M+15.1% | $69.3M |
| Total Liabilities | $194.7M+14.0% | $170.8M |
| Current Liabilities | $160.7M+11.5% | $144.1M |
| Long-Term Debt | $0 | $0 |
| Total Equity | $217.9M+45.3% | $150.0M |
| Retained Earnings | $66.3M+287.4% | $17.1M |
GRDN Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 |
|---|---|---|---|
| Operating Cash Flow | $98.9M | $100.3M+73.0% | $58.0M |
| Capital Expenditures | N/A | $13.4M-8.8% | $14.7M |
| Free Cash Flow | N/A | $86.8M+100.8% | $43.3M |
| Investing Cash Flow | -$22.7M | -$32.2M-6.0% | -$30.4M |
| Financing Cash Flow | -$5.1M | -$7.1M+70.1% | -$23.6M |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
GRDN Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples.
| Metric | FY25 | FY24 |
|---|---|---|
| Gross Margin | 20.2%+0.3pp | 19.9% |
| Operating Margin | 5.0%+10.1pp | -5.1% |
| Net Margin | 3.4%+12.4pp | -9.0% |
| Return on Equity | 22.6%+96.0pp | -73.4% |
| Return on Assets | 11.9%+46.2pp | -34.3% |
| Current Ratio | 1.38+0.3x | 1.05 |
| Debt-to-Equity | 0.000.0x | 0.00 |
| FCF Margin | 6.0%+2.5pp | 3.5% |
Similar Companies
Where Guardian Pharmacy Services, Inc. Ranks
Frequently Asked Questions
What is Guardian Pharmacy Services, Inc.'s annual revenue?
Guardian Pharmacy Services, Inc. (GRDN) reported $1.4B in total revenue for fiscal year 2025. This represents a 17.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Guardian Pharmacy Services, Inc.'s revenue growing?
Guardian Pharmacy Services, Inc. (GRDN) revenue grew by 17.9% year-over-year, from $1.2B to $1.4B in fiscal year 2025.
Is Guardian Pharmacy Services, Inc. profitable?
Yes, Guardian Pharmacy Services, Inc. (GRDN) reported a net income of $49.2M in fiscal year 2025, with a net profit margin of 3.4%.
What is Guardian Pharmacy Services, Inc.'s EBITDA?
Guardian Pharmacy Services, Inc. (GRDN) had EBITDA of $95.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Guardian Pharmacy Services, Inc. have?
As of fiscal year 2025, Guardian Pharmacy Services, Inc. (GRDN) had $65.6M in cash and equivalents against $0 in long-term debt.
What is Guardian Pharmacy Services, Inc.'s gross margin?
Guardian Pharmacy Services, Inc. (GRDN) had a gross margin of 20.2% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Guardian Pharmacy Services, Inc.'s operating margin?
Guardian Pharmacy Services, Inc. (GRDN) had an operating margin of 5.0% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Guardian Pharmacy Services, Inc.'s net profit margin?
Guardian Pharmacy Services, Inc. (GRDN) had a net profit margin of 3.4% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Guardian Pharmacy Services, Inc.'s return on equity (ROE)?
Guardian Pharmacy Services, Inc. (GRDN) has a return on equity of 22.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Guardian Pharmacy Services, Inc.'s free cash flow?
Guardian Pharmacy Services, Inc. (GRDN) generated $86.8M in free cash flow during fiscal year 2025. This represents a 100.8% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Guardian Pharmacy Services, Inc.'s operating cash flow?
Guardian Pharmacy Services, Inc. (GRDN) generated $100.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Guardian Pharmacy Services, Inc.'s total assets?
Guardian Pharmacy Services, Inc. (GRDN) had $412.7M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Guardian Pharmacy Services, Inc.'s capital expenditures?
Guardian Pharmacy Services, Inc. (GRDN) invested $13.4M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is Guardian Pharmacy Services, Inc.'s current ratio?
Guardian Pharmacy Services, Inc. (GRDN) had a current ratio of 1.38 as of fiscal year 2025, which is considered adequate.
What is Guardian Pharmacy Services, Inc.'s debt-to-equity ratio?
Guardian Pharmacy Services, Inc. (GRDN) had a debt-to-equity ratio of 0.00 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Guardian Pharmacy Services, Inc.'s return on assets (ROA)?
Guardian Pharmacy Services, Inc. (GRDN) had a return on assets of 11.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Guardian Pharmacy Services, Inc.'s Altman Z-Score?
Guardian Pharmacy Services, Inc. (GRDN) has an Altman Z-Score of 11.90, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Guardian Pharmacy Services, Inc.'s Piotroski F-Score?
Guardian Pharmacy Services, Inc. (GRDN) has a Piotroski F-Score of 6 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Guardian Pharmacy Services, Inc.'s earnings high quality?
Guardian Pharmacy Services, Inc. (GRDN) has an earnings quality ratio of 2.04x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Guardian Pharmacy Services, Inc. cover its interest payments?
Guardian Pharmacy Services, Inc. (GRDN) has an interest coverage ratio of 109.32x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Guardian Pharmacy Services, Inc.?
Guardian Pharmacy Services, Inc. (GRDN) scores 54 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.